Answer
ENFLONSIA (clesrovimab) is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season, in accordance with official recommendations.
Sources for this answer
- ENFLONSIA® 105 mg solution for injection in pre-filled syringeMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked